The mutation status of the epidermal growth factor receptor (EGFR) as a selection criterion for therapy with EGFR tyrosine kinase inhibitors (TKI's) in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Mathy, A. [1 ]
Nederlof, P. [1 ]
Boerrigter, L. [1 ]
Van 't Veer, L. [1 ]
De Jong, D. [1 ]
Baas, P. [1 ]
Burgers, S. [1 ]
Van Zandwijk, N. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10073
引用
收藏
页码：558S / 558S
页数：1
相关论文
共 50 条
  • [21] Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
    Schettino, Clorinda
    Bareschino, Maria Anna
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    [J]. CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 226 - 235
  • [22] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [23] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Rocco, G.
    Galetta, D.
    Montagna, E. S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, C.
    Perrone, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [24] Prevalence of epidermal growth factor receptor (EGFR) mutation in an Ecuadorian population with non-small cell lung cancer (NSCLC).
    Rivas, Carmen
    Martinez, Luis A.
    Eduardo Teran, Enrique
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) IN AN IRISH POPULATION
    Graham, Donna M.
    O'Connor, Kate
    Teo, Min Y.
    Burke, Louise
    Mccarthy, Julie
    O'Dea, Pauline
    O'Keefe, Margaret
    Moylan, Eugene J.
    Power, Derek G.
    O'Reilly, Seamus
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1527 - S1528
  • [26] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [27] Impact of epidermal growth factor receptor (EGFR) mutations on responsiveness of non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors (TKIS): Prospective observations
    van Zandwijk, Nico
    Mathy, Alexandre
    de Jong, Daphne
    Baas, Paul
    Burgers, Sjaak
    Nederlof, Petra
    [J]. EJC SUPPLEMENTS, 2006, 4 (06): : 14 - 15
  • [28] Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Miller, Vincent A.
    Riely, Gregory J.
    Arcila, Maria E.
    Oxnard, Geoffrey
    Zakowski, Maureen F.
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S314 - S314
  • [29] RICTOR signaling modulates the activity of EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutated non-small cell lung cancer (NSCLC)
    Fan, Ni
    Zou, Yiyu
    Halmos, Balazs
    Perez-Soler, Roman
    Cheng, Haiying
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [30] Tyrosine Kinase-Inhibitors effective in epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCL)
    Pommer, Peter
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (18) : 1284 - 1284
12345